Researchers found that the common blood pressure drug telmisartan can significantly improve the performance of the cancer ...
The 68-year-old previously told how his diagnosis came as a 'real bolt from the blue' ...
Researchers have uncovered a rare inherited mutation linked to prostate cancer—and it could help identify at-risk families ...
British drugmaker GSK said on Friday its experimental drug for treating patients with advanced or relapsed small-cell lung ...
Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
NeoGenomics, Inc.(NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the launch of PTEN IHC CDx, the first immunohistochemistry (IHC) ...
Researchers at the University of British Columbia have identified a new form of hereditary prostate cancer that, while rare, ...
Researchers at the University of British Columbia have identified a new form of hereditary prostate cancer that, while rare, ...
OSLO, Norway, June 8, 2026 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, and Artera, a leading precision medicine company, announce launch of a joint research initiative. The ...
CorePlus, Puerto Rico’s fully digital precision pathology and clinical laboratory, announced today the integration of the ArteraAI Prostate Test into its diagnostic workflows, becoming the first ...
The Alberta Cancer Foundation is investing $35-million to advance cancer clinical trials in Alberta. The amount represents one of the largest investments into clinical trials over a five-year window ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results